Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration

C. E. Briggs, D. Rucinski, Philip J Rosenfeld, T. Hirose, E. L. Berson, T. P. Dryja

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Purpose. To determine the spectrum of ABCR mutations associated with Stargardt macular degeneration and cone-rod degeneration (CRD). Methods. One hundred eighteen unrelated patients with recessive Stargardt macular degeneration and eight with recessive CRD were screened for mutations in ABCR (ABCA4) by singlestrand conformation polymorphism analysis. Variants were characterized by direct genomic sequencing. Segregation analysis was performed on the families of 20 patients in whom at least two or more likely pathogenic sequence changes were identified. Results. The authors found 77 sequence changes likely to be pathogenic: 21 null mutations (15 novel), 55 missense changes (26 novel), and one deletion of a consensus glycosylation site (also novel). Fifty-two patients with Stargardt macular degeneration (44% of those screened) and five with CRD each had two of these sequence changes or were homozygous for one of them. Segregation analyses in the families of 19 of these patients were informative and revealed that the index cases and all available affected siblings were compound heterozygotes or homozygotes. The authors found one instance of an apparently de novo mutation, Ile824Thr, in a patient. Thirty-seven (31%) of the 118 patients with Stargardt disease and one with CRD had only one likely pathogenic sequence change. Twenty-nine patients with Stargardt disease (25%) and two with CRD had no identified sequence changes. Conclusions: This report of 42 novel mutations brings the growing number of identified likely pathogenic sequence changes in ABCR to approximately 250.

Original languageEnglish
Pages (from-to)2229-2236
Number of pages8
JournalInvestigative Ophthalmology and Visual Science
Volume42
Issue number10
StatePublished - Sep 26 2001
Externally publishedYes

Fingerprint

Mutation
Homozygote
Heterozygote
Cone-Rod Dystrophies
Stargardt disease 1
Glycosylation
Siblings

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration. / Briggs, C. E.; Rucinski, D.; Rosenfeld, Philip J; Hirose, T.; Berson, E. L.; Dryja, T. P.

In: Investigative Ophthalmology and Visual Science, Vol. 42, No. 10, 26.09.2001, p. 2229-2236.

Research output: Contribution to journalArticle

Briggs, C. E. ; Rucinski, D. ; Rosenfeld, Philip J ; Hirose, T. ; Berson, E. L. ; Dryja, T. P. / Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration. In: Investigative Ophthalmology and Visual Science. 2001 ; Vol. 42, No. 10. pp. 2229-2236.
@article{b5c69a04785a4835a353b76d7bca9921,
title = "Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration",
abstract = "Purpose. To determine the spectrum of ABCR mutations associated with Stargardt macular degeneration and cone-rod degeneration (CRD). Methods. One hundred eighteen unrelated patients with recessive Stargardt macular degeneration and eight with recessive CRD were screened for mutations in ABCR (ABCA4) by singlestrand conformation polymorphism analysis. Variants were characterized by direct genomic sequencing. Segregation analysis was performed on the families of 20 patients in whom at least two or more likely pathogenic sequence changes were identified. Results. The authors found 77 sequence changes likely to be pathogenic: 21 null mutations (15 novel), 55 missense changes (26 novel), and one deletion of a consensus glycosylation site (also novel). Fifty-two patients with Stargardt macular degeneration (44{\%} of those screened) and five with CRD each had two of these sequence changes or were homozygous for one of them. Segregation analyses in the families of 19 of these patients were informative and revealed that the index cases and all available affected siblings were compound heterozygotes or homozygotes. The authors found one instance of an apparently de novo mutation, Ile824Thr, in a patient. Thirty-seven (31{\%}) of the 118 patients with Stargardt disease and one with CRD had only one likely pathogenic sequence change. Twenty-nine patients with Stargardt disease (25{\%}) and two with CRD had no identified sequence changes. Conclusions: This report of 42 novel mutations brings the growing number of identified likely pathogenic sequence changes in ABCR to approximately 250.",
author = "Briggs, {C. E.} and D. Rucinski and Rosenfeld, {Philip J} and T. Hirose and Berson, {E. L.} and Dryja, {T. P.}",
year = "2001",
month = "9",
day = "26",
language = "English",
volume = "42",
pages = "2229--2236",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "10",

}

TY - JOUR

T1 - Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration

AU - Briggs, C. E.

AU - Rucinski, D.

AU - Rosenfeld, Philip J

AU - Hirose, T.

AU - Berson, E. L.

AU - Dryja, T. P.

PY - 2001/9/26

Y1 - 2001/9/26

N2 - Purpose. To determine the spectrum of ABCR mutations associated with Stargardt macular degeneration and cone-rod degeneration (CRD). Methods. One hundred eighteen unrelated patients with recessive Stargardt macular degeneration and eight with recessive CRD were screened for mutations in ABCR (ABCA4) by singlestrand conformation polymorphism analysis. Variants were characterized by direct genomic sequencing. Segregation analysis was performed on the families of 20 patients in whom at least two or more likely pathogenic sequence changes were identified. Results. The authors found 77 sequence changes likely to be pathogenic: 21 null mutations (15 novel), 55 missense changes (26 novel), and one deletion of a consensus glycosylation site (also novel). Fifty-two patients with Stargardt macular degeneration (44% of those screened) and five with CRD each had two of these sequence changes or were homozygous for one of them. Segregation analyses in the families of 19 of these patients were informative and revealed that the index cases and all available affected siblings were compound heterozygotes or homozygotes. The authors found one instance of an apparently de novo mutation, Ile824Thr, in a patient. Thirty-seven (31%) of the 118 patients with Stargardt disease and one with CRD had only one likely pathogenic sequence change. Twenty-nine patients with Stargardt disease (25%) and two with CRD had no identified sequence changes. Conclusions: This report of 42 novel mutations brings the growing number of identified likely pathogenic sequence changes in ABCR to approximately 250.

AB - Purpose. To determine the spectrum of ABCR mutations associated with Stargardt macular degeneration and cone-rod degeneration (CRD). Methods. One hundred eighteen unrelated patients with recessive Stargardt macular degeneration and eight with recessive CRD were screened for mutations in ABCR (ABCA4) by singlestrand conformation polymorphism analysis. Variants were characterized by direct genomic sequencing. Segregation analysis was performed on the families of 20 patients in whom at least two or more likely pathogenic sequence changes were identified. Results. The authors found 77 sequence changes likely to be pathogenic: 21 null mutations (15 novel), 55 missense changes (26 novel), and one deletion of a consensus glycosylation site (also novel). Fifty-two patients with Stargardt macular degeneration (44% of those screened) and five with CRD each had two of these sequence changes or were homozygous for one of them. Segregation analyses in the families of 19 of these patients were informative and revealed that the index cases and all available affected siblings were compound heterozygotes or homozygotes. The authors found one instance of an apparently de novo mutation, Ile824Thr, in a patient. Thirty-seven (31%) of the 118 patients with Stargardt disease and one with CRD had only one likely pathogenic sequence change. Twenty-nine patients with Stargardt disease (25%) and two with CRD had no identified sequence changes. Conclusions: This report of 42 novel mutations brings the growing number of identified likely pathogenic sequence changes in ABCR to approximately 250.

UR - http://www.scopus.com/inward/record.url?scp=0034854473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034854473&partnerID=8YFLogxK

M3 - Article

C2 - 11527935

AN - SCOPUS:0034854473

VL - 42

SP - 2229

EP - 2236

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 10

ER -